Overview of HIV Prevention
Summary
- Injectable formulations of antiretroviral drugs could improve the efficacy of PrEP by enhancing adherence
- Sustained-release formulations of rilpivirine and cabotegravir are under investigation[Jackson 2012; Markowitz 2017; Landovitz 2018; Landovitz 2020]
- A dapivirine-containing vaginal ring reduces rate of HIV infection by approximately 30% in 2 phase III clinical trials[Baeten 2016b; Nel 2016]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content
Keywords: Biomedical Prevention